New findings reveal phenotypic clusters in pediatric Behçet’s disease, offering insights into its variable presentation and highlighting the need for improved diagnostic awareness in children.

New findings reveal phenotypic clusters in pediatric Behçet’s disease, offering insights into its variable presentation and highlighting the need for improved diagnostic awareness in children.

When to use apremilast and biologics and how to deal with vascular involvement were some of the main areas to be updated in forthcoming EULAR recommendations for Behçet's disease.

Behçet's disease represents an epitome of how focused research and advocacy can foster broader investment in rare diseases, paving the way for advancements in understanding, treatment, and policy.

Keywords: Behçet’s disease, myelodysplastic syndrome, trisomy 8, upadacitinib, JAK-STAT pathway, refractory disease Citation: Wang Y, Tian F and Li H (2025) Upadacitinib for refractory Behçet’s ...

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company developing therapies for rare diseases with unmet medical needs, issued a shareholder update outlining key clinical and strategic ...

Behçet's is believed to be an autoimmune disorder. For unknown reasons, the immune system doesn’t work properly and attacks blood vessels. Although the cause is not understood, certain genes make some ...

Behçet disease is a chronic multisystem inflammatory disorder with oral and genital ulcers present in up to 95% of patients. Skin manifestations are often papulopustular rashes or erythema ...

Soligenix's Treatment Of Behçet's Disease Soligenix's drug candidate for treating Behçet’s disease is SGX945. Dusquetide, the active ingredient in SGX945, is an innate defense regulator (IDR ...

In a new scientific model, researchers explore the role of stress granules on cell function, tying it to a potential cause for Alzheimer's disease.